Notice: This company has been marked as potentially delisted and may not be actively trading. BioTelemetry (BEAT) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesShort InterestTrends BEAT vs. RCEL, CVRX, OSUR, ANIK, LUNG, CATX, PROF, DRTS, UTMD, and ARAYShould you be buying BioTelemetry stock or one of its competitors? The main competitors of BioTelemetry include AVITA Medical (RCEL), CVRx (CVRX), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), Pulmonx (LUNG), Perspective Therapeutics (CATX), Profound Medical (PROF), Alpha Tau Medical (DRTS), Utah Medical Products (UTMD), and Accuray (ARAY). These companies are all part of the "surgical & medical instruments" industry. BioTelemetry vs. AVITA Medical CVRx OraSure Technologies Anika Therapeutics Pulmonx Perspective Therapeutics Profound Medical Alpha Tau Medical Utah Medical Products Accuray AVITA Medical (NASDAQ:RCEL) and BioTelemetry (NASDAQ:BEAT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, community ranking, institutional ownership, valuation, risk, dividends, profitability, media sentiment and analyst recommendations. Which has stronger earnings and valuation, RCEL or BEAT? BioTelemetry has lower revenue, but higher earnings than AVITA Medical. AVITA Medical is trading at a lower price-to-earnings ratio than BioTelemetry, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAVITA Medical$60.04M5.14-$35.38M-$2.23-5.28BioTelemetryN/AN/A-$14.64M-$0.68-3.57 Which has more volatility & risk, RCEL or BEAT? AVITA Medical has a beta of 1.6, meaning that its stock price is 60% more volatile than the S&P 500. Comparatively, BioTelemetry has a beta of -0.83, meaning that its stock price is 183% less volatile than the S&P 500. Does the media prefer RCEL or BEAT? In the previous week, AVITA Medical had 3 more articles in the media than BioTelemetry. MarketBeat recorded 4 mentions for AVITA Medical and 1 mentions for BioTelemetry. AVITA Medical's average media sentiment score of 0.25 beat BioTelemetry's score of 0.00 indicating that AVITA Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AVITA Medical 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral BioTelemetry 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals believe in RCEL or BEAT? 27.7% of AVITA Medical shares are owned by institutional investors. Comparatively, 7.8% of BioTelemetry shares are owned by institutional investors. 1.8% of AVITA Medical shares are owned by company insiders. Comparatively, 20.9% of BioTelemetry shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts rate RCEL or BEAT? AVITA Medical currently has a consensus target price of $16.50, indicating a potential upside of 40.19%. BioTelemetry has a consensus target price of $8.00, indicating a potential upside of 229.22%. Given BioTelemetry's stronger consensus rating and higher probable upside, analysts plainly believe BioTelemetry is more favorable than AVITA Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AVITA Medical 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33BioTelemetry 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is RCEL or BEAT more profitable? BioTelemetry has a net margin of 0.00% compared to AVITA Medical's net margin of -95.47%. BioTelemetry's return on equity of -175.50% beat AVITA Medical's return on equity.Company Net Margins Return on Equity Return on Assets AVITA Medical-95.47% -194.69% -60.67% BioTelemetry N/A -175.50%-154.96% Does the MarketBeat Community favor RCEL or BEAT? BioTelemetry received 317 more outperform votes than AVITA Medical when rated by MarketBeat users. However, 67.89% of users gave AVITA Medical an outperform vote while only 63.37% of users gave BioTelemetry an outperform vote. CompanyUnderperformOutperformAVITA MedicalOutperform Votes7467.89% Underperform Votes3532.11% BioTelemetryOutperform Votes39163.37% Underperform Votes22636.63% SummaryBioTelemetry beats AVITA Medical on 9 of the 16 factors compared between the two stocks. Ad Brownstone ResearchCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.Click here to see the details because I believe a lot of people will get rich. Get BioTelemetry News Delivered to You Automatically Sign up to receive the latest news and ratings for BEAT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BEAT vs. The Competition Export to ExcelMetricBioTelemetrySurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$64.81M$4.34B$5.14B$9.08BDividend YieldN/A44.57%5.09%4.23%P/E Ratio-3.5725.3790.1317.18Price / SalesN/A45.881,116.34117.09Price / CashN/A43.4043.1037.85Price / Book3.987.094.784.78Net Income-$14.64M$13.64M$120.31M$225.60M BioTelemetry Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BEATBioTelemetry1.6283 of 5 stars$2.43+2.1%$8.00+229.2%+46.4%$64.81MN/A-3.571,700RCELAVITA Medical1.6375 of 5 stars$12.47+2.1%$16.50+32.3%-6.4%$326.96M$50.14M-5.48130News CoverageCVRXCVRx3.7891 of 5 stars$13.24+3.2%$16.67+25.9%-52.2%$321.26M$47.26M-4.75200Positive NewsOSUROraSure Technologies4.3617 of 5 stars$4.00+2.3%$5.50+37.5%-55.2%$298.38M$224.26M27.60638News CoverageGap DownANIKAnika Therapeutics3.0387 of 5 stars$16.88-1.6%$24.50+45.1%-28.0%$247.22M$164.17M-2.58357LUNGPulmonx2.6855 of 5 stars$6.11+0.2%$12.75+108.7%-51.4%$241.27M$79.30M-4.15250Gap DownCATXPerspective Therapeutics3.2918 of 5 stars$3.43-1.4%$15.14+341.5%N/A$231.83M$1.43M0.00116Positive NewsPROFProfound Medical2.3412 of 5 stars$7.26-1.9%$13.75+89.4%-20.6%$218.02M$7.20M-5.52150News CoverageHigh Trading VolumeDRTSAlpha Tau Medical1.978 of 5 stars$3.09+0.7%$8.00+158.9%+5.4%$216.07MN/A-7.1480UTMDUtah Medical Products3.0499 of 5 stars$62.95+0.5%N/A-27.7%$213.40M$50.22M14.73180Positive NewsARAYAccuray4.5815 of 5 stars$1.97+2.3%$9.00+358.0%-35.5%$197.61M$444.20M-11.29987News Coverage Related Companies and Tools Related Companies AVITA Medical Alternatives CVRx Alternatives OraSure Technologies Alternatives Anika Therapeutics Alternatives Pulmonx Alternatives Perspective Therapeutics Alternatives Profound Medical Alternatives Alpha Tau Medical Alternatives Utah Medical Products Alternatives Accuray Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BEAT) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioTelemetry, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioTelemetry With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BEAT Stock Alerts